Evidence map›Paper›PMID 27392038›Full record

ReviewAnnals of the New York Academy of Sciences2016

Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment.

Jerome Niquet, Roger Baldwin, Lucie Suchomelova, Lucille Lumley, David Naylor, Roland Eavey, Claude G Wasterlain

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Treatment considerations for the management of neonatal onset seizures.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2025
    Article
  4. Roles of funny HCN.Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Effectiveness and safety of Perampanel in refractory status epilepticus: a case series.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  10. Review
  11. Article
  12. Pharmacology of Adenosine ANeurotoxicity research · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jerome NiquetDepartment of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California. jniquet@ucla.edu.
Roger BaldwinEpilepsy Research Laboratory (151), Veterans Affairs Greater Los Angeles Healthcare System, West Los Angeles, California.
Lucie SuchomelovaEpilepsy Research Laboratory (151), Veterans Affairs Greater Los Angeles Healthcare System, West Los Angeles, California.
Lucille LumleyU.S. Army Medical Research Institute of Chemical Defense (USAMRICD), Aberdeen Proving Ground, Aberdeen, Maryland.
David NaylorDepartment of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California.
Roland EaveyEpilepsy Research Laboratory (151), Veterans Affairs Greater Los Angeles Healthcare System, West Los Angeles, California.
Claude G WasterlainDepartment of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California.
West Los Angeles College · USUnited States Army · USUniversity of California, Los Angeles · USVA Greater Los Angeles Healthcare System · US

Funding

Rational polytherapy in the treatment of cholinergic seizuresU01NS074926 · NINDS · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI WASTERLAIN, CLAUDE G · 2011 to 2015
$3.3M
Treatment of Status Epilepticus: A Translational ProposalI01BX000273 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI WASTERLAIN, CLAUDE G · 2009 to 2017
–
BLRD VA I01 BX000273NINDS NIH HHS U01 NS074926
6 · The paper itself

Abstract

Cholinergic status epilepticus (CSE) quickly becomes self-sustaining, independent of its initial trigger, and resistant to benzodiazepines and other antiepileptic drugs. We review a few of the many physiological changes associated with CSE, with an emphasis on receptor trafficking. Time-dependent internalization of synaptic γ-aminobutyric acid (GABA)

Indexed as

AnimalsAnticonvulsantsBenzodiazepinesGABA-A Receptor AntagonistsHumansReceptors, GABA-AStatus EpilepticusTreatment OutcomeAnticonvulsantsBenzodiazepinesGABA-A Receptor AntagonistsReceptors, GABA-Acholinergic seizuresnerve agentpharmacoresistancepolytherapyrefractory status epilepticus

Identifiers

PMID27392038
PMCPMC5063678
OpenAlexW2474255262

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.